Gastroenterology
Volume 137, Issue 1 , Pages 20-22 , July 2009

Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat

  • Kenneth E.L. McColl

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Kenneth E. L. McColl, MD, Division of Cardiovascular & Medical Sciences, University of Glasgow, Gardiner Institute, 44 Church Street, Glasgow, G11 6NT, UK
    • ,
  • Derek Gillen

References 

  1. Danish Medicines Agency. Medicinal product statistics in Denmark 2007. Copenhagen: Danish Medicines Agency; 2008;
  2. Forgacs I, Loganayagam A. Over-prescribing proton pump inhibitors. BMJ. 2008;336:2–3
  3. Reimer C, Søndergaard B, Hilsted L, et al. Proton pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137:80–87
  4. Gillen D, Wirz AA, Neithercut WD, et al. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut. 1999;44:468–475
  5. Kuipers EJ, Lundell L, Klinkenberg-Knol E, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018–1022
  6. Larsson H, Carlsson E, Mattsson H, et al. Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology. 1986;90:391–399
  7. Carlsson E, Larsson H, Mattsson H, et al. Pharmacology and toxicology of omeprazole—with special reference to the effects on gastric mucosa. Scand J Gastroenterol. 1986;21(Suppl 118):31–38
  8. Waldum HL, Arnestad JS, Brenna E, et al. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut. 1996;39:649–653
  9. Gillen D, Wirz AA, Ardill JE, et al. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology. 1999;116:239–247
  10. Gillen D, Wirz AA, McColl KEL. Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment. Gastroenterology. 2004;126(4):980–988
  11. Niklasson A, Lindstrom L, Simren M, et al. Dyspeptic symptoms development after discontinuation of a proton pump inhibitor: clinical importance of acid-rebound. Gastroenterology. 2008;134(Suppl 1):797
  12. National Institute for Clinical Excellence. NICE Clinical Guideline 17 (Dyspepsia-management of dyspepsia in adults in primary care). London: Author; 2004;
  13. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100:2324–2337
  14. Talley NJ, Meineche-Schmidt V, Pare P National Institute for Clinical Excellence. Efficacy of omeprazole in functional dyspepsia: double-blind, randomised, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998;12:1055–1065
  15. Fullarton GM, McLauchlan G, Macdonald A, et al. Rebound nocturnal hypersecretion after four weeks treatment with an H2-receptor antagonist. Gut. 1989;30:449–454
  16. Fullarton GM, Macdonald AMI, McColl KEL. Rebound hypersecretion after H2-antagonist withdrawal—a comparative study with nizatidine, ranitidine and famotidine. Aliment Pharmacol Ther. 1991;5:391–398
  17. Smith AD, Gillen D, Cochran KM, et al. dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers. Am J Gastroenterol. 1999;94:1209–1213
  18. Jensen RT. CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders. Yale J Biol Med. 1996;69:245–259
  19. Murphy MG, Sytnik B, Kovacs TOG, et al. The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans. Clin Pharmacol Ther. 1993;54:533–539
  20. Nishida A, Kobayashi-Uchida A, Akuzawa S, et al. Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression. Am J Physiol. 1995;269:G699–G705

 Conflicts of interest The authors disclose no conflicts.

PII: S0016-5085(09)00780-X

doi: 10.1053/j.gastro.2009.05.015

Gastroenterology
Volume 137, Issue 1 , Pages 20-22 , July 2009

Article Tools

* Image Usage & Resolution